Author/Editor		Hindle, Don; Yazbeck, Anne-Marie; Wahl, Jana
Title		Klinične poti v 17 državah evropske unije: pregled mnenj strokovnjakov
Translated title		Clinical pathways in 17 European union countries: a survey of expert opinions
Type		članek
Source		Zdrav Vestn
Vol. and No.		Letnik 73, št. 11
Publication year		2004
Volume		str. 839-45
Language		slo
Abstract		Background. The main focus of the survey is on the extent to which clinical pathways are being used, and whether it might provide a basis for improved service planning and consequently strategic asset planning in health care. Methods. In the first stage, our aim was to make contact with one agency in each country (the primary agency below) that would he able to provide contacts within that country with a mix of experts from each of the following types of agencies: Health sector government regulator, Health care purchasing (insurance) agencies, Senior clinical managers in hospitals, Senior clinical managers in non-hospital care provider agencies (eg, home care, or primary medical care), Health professional societies (preferably medical and nursing), Accreditation or audit agencies, Consumer associations and Public or private agencies concerned with health facilities development Definitions of these agencies and other terms were attached to the questionnaire itself. We would then ask the primary agency to choose the experts that were most likely to be aware of clinical pathway use. The persons thus contacted would then be asked to complete the questionnaire and send it back to the researchers. The aim was not to attempt to establish a random sample, but rather to target well-informed people. Results. 51 completed questionnaires were provided by largely self-selected experts from 17 EU countries. Respondents reported that pathways are important and becoming increasingly widely used (although the rate of progress is highly variable), the main constraints to their use are a cultural aversion among doctors and little encouragement from external parties, and there is growing recognition that multi-setting pathways have the greatest potential value. (Abstract truncated at 2000 characters).
Summary		Izhodišča. Namen raziskave je bil ugotoviti, v kolikšni meri se klinične poti uporabljajo in/ali nam lahko podajo izhodišče za boljše načrtovanje zdravstvenih storitev. Metode. Navezali smo stike z ustanovami oziroma primarnimi agencijami iz vsake države, ki smo jih zaprosili, da nas povežejo z različnimi strokovnjaki iz osmih tipov agencij: ministrstvo za zdravje, zavarovalnice, izkušeni upravitelji bolnišnic ali kliničnih oddelkov, izkušeni upravitelji zdravstvenih domov ali domov za starejše občane, zbornice in društva zdravnikov in medicinskih sester, agencije za akreditacijo ali presojo, društva potrošnikov in javne ali zasebne agencije za načrtovanje investicij v zdravstvu. Definicije vrst agencij in pojasnila uporabljenih izrazov smo podali v dodatku k anketi, ki so na voljo pri avtorjih. Vsako primarno agencijo smo prosili, da izbere strokovnjake, ki so z uporabo kliničnih poti najbolje seznanjeni. Izbranim strokovnjakom smo razposlali vprašalnike. Cilj raziskave ni bil izbrati naključen vzorec anketirancev, ampak se osredotočiti na dobro obveščene ljudi. Rezultati. Izpolnjene vprašalnike nam je vrnilo 51 izbranih strokovnjakov iz 17 držav EU. Iz rezultatov je razvidno, da so klinične poti pomembne ter da se v klinični praksi čedalje bolj uporabljajo (čeprav so stopnje napredka zelo različne). Glavne ovire za še širšo uporabo so odpor med zdravniki ter pomanjkanje spodbude s strani zunanjih udeležencev (zavarovalnice, zbornice, agencije za akreditacijo, ministrstvo za zdravje itd.). Iz rezultatov je tudi razvidno, da so najučinkovitejše klinične poti tiste, ki opisujejo (združujejo) več dejavnosti zdravstvene oskrbe. (Izvleček skrajšan pri 2000 znakih).
Descriptors		CRITICAL PATHWAYS HEALTH SERVICES HEALTH CARE COSTS HEALTH POLICY QUESTIONNAIRES EUROPEAN ECONOMIC COMMUNITY